I am aware of where MGF comes from. Unless datbtrue is working alongside one of the few researchers in the world that is publishing data on MGF, I would be very suspicious of his statements. Peptides generally have receptors (this is what nature uses them for), and it would be very unlikely that MGF transduced signals through the IGF-1 receptor due to their vastly different primary sequence and secondary structures. Hence something else is probably at play.
It is also important to remember that MGF was only discovered in the past 10 years and not a lot of work has been done examining its biology. IGF-1 has been studied for much longer.
But to exemplify the lack of knowledge the field has on this hormone, look towards this recent publication that merely examines to see if MGF acts through the same pathways as IGF-1:
Mol Med. 2009 Mar 19.
IGF-1 Expression in Infarcted Myocardium and MGF E Peptide Actions on Rat Cardiomyocytes, In Vitro.
Stavropoulou A, Halapas A, Sourla A, Philippou A, Papageorgiou E, Papalois A, Koutsilieris M.
Department of Experimental Physiology, MedicalSchool, National Kapodistrian University of Athens, Goudi-Athens, Greece.
Insulin-like growth factor-1 (IGF-1) expression is implicated in myocardial pathophysiology and two IGF-1 mRNA splice variants have been detected in rodents, namely the IGF-1Ea and the mechano-growth factor (MGF). Consequently, we have investigated the expression pattern of the IGF-1 gene transcripts in rat myocardium after left anterior descending coronary artery ligation-induced myocardial infarction (1hr up to 8wks). In addition, we characterized IGF-1 and MGF E peptide action and their respective signaling in H9C2 myocardial-like cells, in vitro. IGF-1Ea and MGF expression were significantly increased, both at transcriptional and translational level, during the late post-infarction period (4wks and 8wks) in infracted rat myocardium. Measurements of serum IGF-1 levels in infracted rats were initially decreased (24hr up to 1wk) but remained unaltered throughout the late experimental phase (4wks to 8wks) as compared to this of sham-operated rats. Furthermore, specific anti-IGF-1R neutralizing antibody failed to block the synthetic MGF E peptide action while it blocked completely IGF-1 action on the proliferation of H9C2 cells. Moreover, this synthetic MGF E peptide did not activate Akt phosphorylation while it activated ERK1/2 in H9C2 rat myocardial cells. These data support the role of IGF-1 expression in myocardial repair process and suggest that synthetic MGF E peptide actions are mediated possibly via an IGF-1R independent pathway in rat myocardial cells, as suggested by our in vitro experiments.
-------------------------------
Notice they say no Akt phosphorylation occurred (a hallmark of IGF-1 signaling) whereas ERK1/2 were activated. ERK1/2 activation would suggest the activity of a yet-to-be-identified GPCR.